Effects of Modern Chemotherapy Regimens on Spermatogenesis and Steroidogenesis in Adolescent and Young Adult (AYA) Survivors of Osteosarcoma

Investigating the Effects of Chemotherapy on Fertility in Osteosarcoma Survivors

Recruiting
18 years - 50 years
Male
Phase N/A
1 Location

Brief description of study.

This research trial studies saliva, semen, and blood samples to determine effects of chemotherapy on fertility in osteosarcoma survivors. Study biospecimen samples from osteosarcoma survivors in the laboratory may help doctors learn whether chemotherapy causes fertility problems and to learn more about the long term effects.

Detailed description of study

The purpose of this study is to determine whether infertility and/or biomarkers of spermatogenesis and steroidogenesis differ in male osteosarcoma survivors treated with cisplatin with or without ifosfamide compared to male controls without a history of cancer, and to evaluate whether cisplatin with or without ifosfamide for the treatment of osteosarcoma alters sperm deoxyribonucleic acid (DNA) methylation.
Participants will not be paid for their participation.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: osteosarcoma,bone cancer,cancer,oncology
  • Age: 18 years - 50 years
  • Gender: Male

Inclusion Criteria
Previously enrolled and randomized on AOST0331 or INT0133 (also known as CCG7921 and POG9351)
Osteosarcoma survivors without relapse or a subsequent malignancy other than skin cancer following initial treatment on AOST0331 or INT0133 (also known as CCG7921 and POG9351)
Able to speak, read and write in English or Spanish

Updated on 19 Feb 2024. Study ID: 1712550596 (PHO-PRADHAN-COG-ALTE16C1)

This study investigates the effects of chemotherapy on fertility in male osteosarcoma survivors. Osteosarcoma is a type of bone cancer, and this study aims to understand if the chemotherapy drugs cisplatin, with or without ifosfamide, affect fertility compared to males without a history of cancer. The study also examines if these drugs change sperm DNA and certain biological markers related to sperm production and hormone creation.

Participants will provide saliva, semen, and blood samples. These samples will be studied in a laboratory to check for any changes in fertility and sperm DNA. The study will look for specific biological markers to see if chemotherapy has long-term effects on fertility.

  • Who can participate: Male osteosarcoma survivors who were previously enrolled in specific trials and have not experienced relapse or another cancer can participate. Participants must be able to speak, read, and write in English or Spanish.
  • Study details: Participants will be asked to provide saliva, semen, and blood samples for laboratory analysis. These samples will be used to study potential changes in fertility and DNA caused by chemotherapy.

Find a site

Message sent successfully.
We have submitted the information you provided to the research team at the location you chose. For your records, we have sent a copy of the message to your email address.
If you would like to be informed of other studies that may be of interest to you, you may sign up for Patient Notification Service.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Preferred way of contact label
Race
Ethnicity
Other language

Default Content Message Here